COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
Journal of Clinical Medicine · 21.12.2025 · 15 (1) · 49
DOI: 10.3390/jcm15010049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.12.2025. Verfasst von Melika Valizadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Rehabilitation Research Center (PRRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University o…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Copenhagen Respiratory Research, Novo Nordisk Foundation.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a progressive and preventable respiratory disorder associated with a significantly increased risk of cardiovascular disease (CVD), including ischemic heart disease, heart failure, pulmonary hypertension, and arrhythmias. The association is bidirectional, with CVD adversely affecting COPD prognosis and vice versa. Beyond shared risk factors such as smoking, aging, and socioeconomic status, COPD itself, through mechanisms including systemic inflammation, oxidative stress, hypoxia, and hyperinflation, contributes independently to cardiovascular morbidity and mortality. Recent research has focused on identifying circulating biomarkers that can aid in early detection, risk stratification, and treatment optimization for patients at risk of both conditions. This review summarizes current evidence on the pathophysiological mechanisms linking COPD and CVD, highlights emerging biomarkers with potential prognostic utility for major adverse cardiovascular events (MACE) and all-cause mortality, and it discusses clinical and research implications for biomarker-guided, personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pulmonary Rehabilitation Research Center (PRRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark.
- Copenhagen Respiratory Research, Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte, DK-2630 Copenhagen, Denmark.
- Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Head of Department of Respiratory Medicine and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, MD-2004 Chisinau, Moldova.
ORCID-Profile: Jens-Ulrik Jensen, Alexandr Ceasovschih, Alexandru Corlateanu, Pradeesh Sivapalan
Förderung
- Copenhagen Respiratory Research
- Novo Nordisk Foundation
Zitieren
APA
Valizadeh, M., Jensen, J. U., Ceasovschih, A., Corlateanu, A., & Sivapalan, P. (2025). COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives. Journal of Clinical Medicine, 15(1), 49. https://doi.org/10.3390/jcm15010049
Vancouver
Valizadeh M, Jensen JU, Ceasovschih A, Corlateanu A, Sivapalan P. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives. Journal of Clinical Medicine. 2025;15(1):49. doi:10.3390/jcm15010049
BibTeX
@article{Valizadeh2025,
author = {Valizadeh, Melika and Jensen, Jens-Ulrik and Ceasovschih, Alexandr and Corlateanu, Alexandru and Sivapalan, Pradeesh},
title = {COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {15},
number = {1},
pages = {49},
doi = {10.3390/jcm15010049}
}
EUVIMED